PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2012 | 23 |
| 2013 | 76 |
| 2014 | 98 |
| 2015 | 94 |
| 2016 | 126 |
| 2017 | 167 |
| 2018 | 169 |
| 2019 | 172 |
| 2020 | 197 |
| 2021 | 220 |
| 2022 | 201 |
| 2023 | 172 |
| 2024 | 214 |
| 2025 | 209 |
| 2026 | 139 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Mol Metab"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
PI3K is the dominant signalling pathway recruited by IRS proteins to mediate their effects on metabolism and growth.
- Millership SJ, Tyler-Rubinstein N, Irvine EE, Charalambous M, Choudhury AI, Vernia S, Voshol P, Vidal-Puig A, Foukas LC, Withers DJ.
- Mol Metab. 2026 Oct 6;114:102450. doi: 10.1016/j.molmet.2026.102450. Online ahead of print.
- PMCID: PMC13694759
Millership SJ, et al.Mol Metab. 2026.PMCID: PMC13694759 -
Nisotirostide (LY3457263), a novel NPY2 receptor agonist for type 2 diabetes and obesity: From discovery to clinical proof of concept.
- Briere DA, Leohr JK, Linnebjerg H, Muppidi A, Antonellis M, Antonellis P, Suter TM, Smith LaBell E, Lopes D, Dogra M, Coskun T, Alsina-Fernandez J, Mather KJ.
- Mol Metab. 2026 Oct 3;114:102452. doi: 10.1016/j.molmet.2026.102452. Online ahead of print.
- PMCID: PMC13682355
Briere DA, et al.Mol Metab. 2026.PMCID: PMC13682355 -
DLST-driven metabolic alterations link skin to blood glucose: A translational study from mouse to human.
- Ali N, Rahat ST, Motei D, Mäkelä M, Sharma S, Tulppo M, Juntilla J, Hiltunen JK, Nieminen AI, Ohlmeier S, Vainio S.
- Mol Metab. 2026 Sep 28;114:102439. doi: 10.1016/j.molmet.2026.102439. Online ahead of print.
- PMCID: PMC13682495
Ali N, et al.Mol Metab. 2026.PMCID: PMC13682495 -
Metabolic targeting of ASAH1 in combination with carnosine as a therapeutic strategy for TNBC.
- T Ball P, Mari A, Gupta R.
- Mol Metab. 2026 Sep 30;114:102451. doi: 10.1016/j.molmet.2026.102451. Online ahead of print.
- PMCID: PMC13678044
T Ball P, et al.Mol Metab. 2026.PMCID: PMC13678044 -
Molecular mechanisms of lipid sensing in human cholecystokinin-secreting enteroendocrine cells.
- Santos-Hernández M, Tabbada M, Tamkin N, Li L, Guccio N, Davison A, Smith CA, Kay R, Alcaino C, Baig M, Punnoose A, Xu Y, Bany Bakar R, Reimann F, Gribble FM.
- Mol Metab. 2026 Sep 28;114:102448. doi: 10.1016/j.molmet.2026.102448. Online ahead of print.
- PMCID: PMC13677200
Santos-Hernández M, et al.Mol Metab. 2026.PMCID: PMC13677200 -
Genetics of type 2 diabetes: Beyond single nucleotide variant studies.
- Moya-Valera C, Gallardo-Espinoza MJ, Arita AF, Lara-Hernandez F, Quiroz-Rodriguez ME, Abellan R, Garcia-Garcia AB, Chaves FJ.
- Mol Metab. 2026 Sep 26;113:102449. doi: 10.1016/j.molmet.2026.102449.
- PMCID: PMC13676476
Moya-Valera C, et al.Mol Metab. 2026.PMCID: PMC13676476 -
Biosensor cell array reveals temporal GABA secretion dynamics from pancreatic islets.
- Stis AE, Lazimi CS, Ferreira SM, Cuaycal AE, Smurlick D, Hagan DW, Nakayama T, Gandhi SP, Smith E, Spicer TP, Phelps EA.
- Mol Metab. 2026 Sep 25;114:102447. doi: 10.1016/j.molmet.2026.102447. Online ahead of print.
- PMCID: PMC13677039
Stis AE, et al.Mol Metab. 2026.PMCID: PMC13677039 -
Adult-onset deficiency of β-klotho in the liver reveals a novel role in lipid homeostasis.
- Aaldijk AS, Verzijl CRC, Hovingh MV, Huijkman NCA, Smit M, Kloosterhuis NJ, Mulder NL, Havinga R, Gerding A, Bos T, Koster M, de Graaf M, Wolters JC, van de Sluis B, Struik D, Jonker JW.
- Mol Metab. 2026 Sep 22;113:102443. doi: 10.1016/j.molmet.2026.102443.
- PMCID: PMC13658126
Aaldijk AS, et al.Mol Metab. 2026.PMCID: PMC13658126 -
The circadian clock component NPAS2 is modulated by AMPK and regulates substrate utilization and mitochondrial function in human skeletal muscle cells.
- Rizo-Roca D, Pendergrast LA, Kamble P, Guimarães DSPSF, Dollet L, Björnholm M, Zierath JR.
- Mol Metab. 2026 Sep 19;113:102446. doi: 10.1016/j.molmet.2026.102446.
- PMCID: PMC13653946
Rizo-Roca D, et al.Mol Metab. 2026.PMCID: PMC13653946 -
GNPAT-driven plasmalogen biosynthesis regulates macrophage polarization and protects against obesity-induced inflammation by suppressing PKCδ-STAT1 signaling.
- Yun JY, Ko MS, Hong CH, Yoon JE, Leem J, Kim MO, Kim SJ, Yoo HJ, Cho YK, Baek IJ, Kim YB, Lee KU, Koh EH.
- Mol Metab. 2026 Sep 18;113:102440. doi: 10.1016/j.molmet.2026.102440.
- PMCID: PMC13654497
Yun JY, et al.Mol Metab. 2026.PMCID: PMC13654497